Several signaling pathways such as estrogen receptor signaling, androgen receptor signaling, transforming growth factor beta (TGF-β) signaling and epidermal growth factor (EGF) signaling are involved in EMT in prostate cancer (Montanari et al., 2017). Here, EGF is linked to prostate carcinoma.